Pharma Equity Group A/S Stock

Pharma Equity Group A/S Financial Leverage

The Financial Leverage (Equity Multiplier) of Pharma Equity Group A/S (PEG.CO) as of Aug 15, 2026 is 1.53. In the previous year, Financial Leverage (Equity Multiplier) was 1.34 — a change of 13.76% (higher).

Financial Leverage

1.53

YoY

13.76%

Last updated:

Financial Leverage (Equity Multiplier) of Pharma Equity Group A/S is 2026 1.53 . Financial Leverage (Equity Multiplier) of Pharma Equity Group A/S was 2025 1.34 . It decreases by 13.76% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Pharma Equity Group A/S Stock analysis

What does Pharma Equity Group A/S do? Blue Vision A/S is a company specializing in the development, production, and marketing of underwater technology. It was founded in 1992 and is headquartered in Holstebro, Denmark. The company focuses on underwater lighting, underwater inspection cameras, and underwater communication. It specializes in manufacturing underwater lighting products for the offshore industry, ports, and shipping. It also produces underwater inspection cameras for inspecting underwater structures without the need for divers. In addition, the company has developed devices for underwater communication, which are crucial in the offshore industry and military sector. Blue Vision A/S emphasizes innovation and technology, holding patents and investing in digital technology to improve inspection systems. In summary, Blue Vision A/S specializes in underwater technology and offers solutions for the offshore industry, ports, and shipping. The company is committed to innovation and technology to provide the best solutions to its customers. Pharma Equity Group A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharma Equity Group A/S stock

Financial Leverage (Equity Multiplier) of Pharma Equity Group A/S is 1.53 in 2026.

Financial Leverage (Equity Multiplier) of Pharma Equity Group A/S changed from 1.34 to 1.53, representing a 13.76% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Pharma Equity Group A/S since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Pharma Equity Group A/S with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Pharma Equity Group A/S

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Pharma Equity Group A/S